Increasingly, what determines whether innovation moves safely from idea to impact is not only scientific quality, but cultural literacy: the ability to recognise how different actors understand risk, authority, evidence and responsibility, and to work effectively across those differences.
This is often discussed as a cross-border challenge. In reality, it is just as present within the UK life sciences ecosystem itself — including in established clusters such as Cambridge.
Culture is not nationality
When people hear “culture”, they often think of national differences. In complex sectors such as healthcare, culture shows up in more practical and immediate ways:
- How clinicians interpret professional responsibility
- How regulators assess evidence and sequencing
- How founders, engineers and researchers frame risk and speed
- How patients and the public develop trust in new technologies
Within the Cambridge ecosystem, these differences are often felt at points where worlds meet.
Academic spin-outs, for example, may encounter friction when moving from research excellence into clinical pilots, where scientific promise must be reconciled with patient safety, liability and professional accountability.
Similarly, start-ups scaling innovative technologies may frame progress in terms of speed and iteration, while regulators focus on sequencing, assurance and the long-term consequences of early decisions. None of these perspectives are wrong — but when they are not explicitly aligned, execution risk increases.
A digital health pilot may struggle not because the technology is weak, but because clinicians, technologists and governance leads are operating with different assumptions about what success looks like. The result is friction, delay, or loss of confidence — even when everyone involved is acting in good faith.
Where execution commonly breaks down
Many life sciences organisations are technically strong and mission-driven, yet experience difficulty at key transition points, such as:
- moving from research into clinical pilots
- scaling across multiple partners or delivery sites
- operating under heightened regulatory or media scrutiny
These moments act as informal phase-gates. Assumptions that were workable in earlier stages are suddenly tested under real-world pressure.
At these transition points, cultural blind spots often surface. Decision authority may be assumed rather than clarified. Evidence expectations may be interpreted differently by different stakeholders. Escalation pathways may exist formally, but not function in practice.
What appears to be a delivery problem is frequently a shared understanding problem.
Three levels of cultural capability
From observing execution challenges across healthcare and life sciences settings, it can be helpful to think of cultural literacy as developing in stages.
- Awareness — avoiding repeatable mistakes
At this level, organisations recognise that professional and institutional cultures differ, and that domestic experience does not automatically translate across contexts. Even this basic awareness can prevent common execution errors.
- Practice — embedding what works
More mature organisations move beyond individual experience. They begin to capture and share lessons: how trust is built, where scrutiny typically arises, and how decisions hold up under pressure. Cultural understanding becomes part of organisational memory rather than personal intuition.
- Design — shaping better ways of working
At the most advanced stage, organisations use insights from multiple perspectives to design clearer governance, stronger execution pathways and more resilient delivery models.
Not every organisation needs to reach the third stage immediately. However, organisations that have not yet built awareness or practice often face higher execution risk as complexity increases. For readers, an honest question is not “which level is best?”, but “which level are we currently operating at — and where does that place our next transition?”
Why this matters now
Life sciences innovation increasingly operates in environments that are highly regulated, publicly visible and dependent on trust across professional boundaries. In such settings, cultural misunderstandings rarely remain contained. They can affect patient safety, organisational reputation and long-term viability.
There is also a collective dimension. Organisations are rarely judged in isolation. They are often seen as representatives of a sector, a technology class, or a local ecosystem. In a close-knit cluster such as Cambridge, a failure in responsible execution by one organisation can have reputational consequences that extend beyond the firm itself.
This raises the stakes for execution discipline and reinforces why cultural literacy is not a personal skill, but an organisational responsibility.
A practical reframing
Rather than treating culture as background context, it may be more useful to see it as part of execution readiness.
Questions such as:
- Do we have shared clarity on decision rights at this stage?
- Do we understand how evidence will be judged by different stakeholders?
- Do we know how trust is built — and lost — in this environment?
are as operational as any technical checklist, particularly when asked at key transition points.
A technologically strong solution, for example, may still struggle if it overlooks the professional responsibility clinicians carry when adopting new tools, or the expectations patients and the public place on evidence and accountability. Cultural literacy does not remove these constraints; it helps organisations work responsibly within them.
Before embarking on the next pilot or scale-up phase, it may be worth pausing to audit whether these questions have been addressed with the same rigour as technical and regulatory readiness.
Closing reflection
Cultural literacy is not about being international, nor about avoiding difference. It is about working responsibly in complex systems, where outcomes depend on how well people understand one another under real-world conditions.
As life sciences innovation continues to intersect with healthcare delivery, public trust and societal impact, this capability is likely to become not optional, but essential.
Disclaimer: This article is published by Excellence First Enterprise Consultancy (EFEC). The views expressed reflect EFEC’s analysis and experience and do not represent the official positions of Cambridge Network, its members, or any other organisations referenced.
Main image: The moment of translation — where technical readiness meets professional judgment. ( Image generated by Google Gemini)
